NO902776L - Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer. - Google Patents

Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.

Info

Publication number
NO902776L
NO902776L NO90902776A NO902776A NO902776L NO 902776 L NO902776 L NO 902776L NO 90902776 A NO90902776 A NO 90902776A NO 902776 A NO902776 A NO 902776A NO 902776 L NO902776 L NO 902776L
Authority
NO
Norway
Prior art keywords
procedure
preparation
acetylcholinesterase inhibitors
new
new acetylcholinesterase
Prior art date
Application number
NO90902776A
Other languages
English (en)
Other versions
NO902776D0 (no
NO178374B (no
NO178374C (no
Inventor
Daniel Schirlin
Jean-Noel Collard
Jean-Marie Hornsperger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO902776D0 publication Critical patent/NO902776D0/no
Publication of NO902776L publication Critical patent/NO902776L/no
Publication of NO178374B publication Critical patent/NO178374B/no
Publication of NO178374C publication Critical patent/NO178374C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
NO902776A 1989-06-22 1990-06-21 Analogifremgangsmåte for fremstilling av nye terapeutisk aktive acetylcholinesteraseinhibitorer NO178374C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89401775A EP0403713A1 (en) 1989-06-22 1989-06-22 Novel acetylcholinesterase inhibitors

Publications (4)

Publication Number Publication Date
NO902776D0 NO902776D0 (no) 1990-06-21
NO902776L true NO902776L (no) 1990-12-27
NO178374B NO178374B (no) 1995-12-04
NO178374C NO178374C (no) 1996-03-13

Family

ID=8202963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902776A NO178374C (no) 1989-06-22 1990-06-21 Analogifremgangsmåte for fremstilling av nye terapeutisk aktive acetylcholinesteraseinhibitorer

Country Status (19)

Country Link
EP (2) EP0403713A1 (no)
JP (1) JP2879951B2 (no)
KR (1) KR0139529B1 (no)
CN (1) CN1027759C (no)
AR (1) AR247214A1 (no)
AT (1) ATE119535T1 (no)
AU (1) AU626428B2 (no)
CA (1) CA2019231C (no)
DE (1) DE69017543T2 (no)
DK (1) DK0409676T3 (no)
ES (1) ES2072406T3 (no)
FI (1) FI97619C (no)
HU (1) HU210569B (no)
IE (1) IE66155B1 (no)
IL (1) IL94779A (no)
NO (1) NO178374C (no)
NZ (1) NZ234136A (no)
PT (1) PT94449B (no)
ZA (1) ZA904715B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0611769A1 (en) * 1993-02-16 1994-08-24 Merrell Dow Pharmaceuticals Inc. Silylated acetylcholinesterase inhibitors
US5523442A (en) * 1993-02-16 1996-06-04 Merrell Pharmaceuticals Inc. Silylated acetylcholinesterase inhibitors
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
US5554780A (en) * 1994-05-05 1996-09-10 Merrell Pharmaceuticals Inc. Process for the preparation of 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
US5486638A (en) * 1994-11-08 1996-01-23 Marion Merrell Dow Inc. Process for the preparation of 1-halo-3-trialkysilanyl-benzene derivatives
EP0749972A1 (en) 1995-06-21 1996-12-27 Merrell Pharmaceuticals Inc. A process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
CN1059702C (zh) * 1997-12-30 2000-12-20 中国科学院上海细胞生物学研究所 从哺乳类细胞中获得脑型乙酰胆碱酯酶的方法
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6084117A (en) * 1999-11-22 2000-07-04 Albemarle Corporation Production of silated haloarenes by selective silylation of polyhaloarenes
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
MX362886B (es) 2012-12-13 2019-02-22 H Lundbeck As Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva.
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL25820A (en) * 1966-05-22 1971-02-25 Yissum Res Dev Co Silicon containing beta-hydroxy alpha-phenyl carboxylic acids,their amide and ester derivatives and intermediates for their preparation
US4835099A (en) * 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis

Also Published As

Publication number Publication date
HU210569B (en) 1995-05-29
DK0409676T3 (da) 1995-03-27
AU5758490A (en) 1991-01-03
FI903104A0 (fi) 1990-06-20
EP0409676A1 (en) 1991-01-23
HUT54695A (en) 1991-03-28
KR910000757A (ko) 1991-01-30
AU626428B2 (en) 1992-07-30
CA2019231A1 (en) 1990-12-22
CN1027759C (zh) 1995-03-01
IL94779A (en) 1996-09-12
JPH0338591A (ja) 1991-02-19
ZA904715B (en) 1991-04-24
ATE119535T1 (de) 1995-03-15
JP2879951B2 (ja) 1999-04-05
NZ234136A (en) 1994-04-27
CN1048389A (zh) 1991-01-09
DE69017543T2 (de) 1995-07-06
EP0403713A1 (en) 1990-12-27
IE902252A1 (en) 1991-01-16
FI97619B (fi) 1996-10-15
NO902776D0 (no) 1990-06-21
HU903933D0 (en) 1990-11-28
CA2019231C (en) 2000-07-11
EP0409676B1 (en) 1995-03-08
IE66155B1 (en) 1995-12-13
IE902252L (en) 1990-12-22
PT94449A (pt) 1991-02-08
ES2072406T3 (es) 1995-07-16
FI97619C (fi) 1997-01-27
PT94449B (pt) 1997-02-28
KR0139529B1 (ko) 1998-07-01
DE69017543D1 (de) 1995-04-13
NO178374B (no) 1995-12-04
AR247214A1 (es) 1994-11-30
NO178374C (no) 1996-03-13

Similar Documents

Publication Publication Date Title
NO903314D0 (no) Fremgangsmaate for fremstilling av nye peptidaseinhibitorer
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO871727D0 (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
NO880452L (no) Fremgangsmaate for fremstilling av nye polyaminderivater.
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO904285D0 (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO892543D0 (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO901813L (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO904372D0 (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO900074L (no) Fremgangsmaate for fremstilling av nye tetralinderivater.
NO892977D0 (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO904069D0 (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO911118L (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO890644D0 (no) Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO901422L (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO900935D0 (no) Fremgangsmaate for fremstilling av nye piperidinderivater.
NO902293L (no) Fremgangsmaate for fremstilling av nye tiazepinderivater.
NO893006D0 (no) Fremgangsmaate for fremstilling av nye allylaminoetylazoler
NO901401D0 (no) Fremgangsmaate for fremstilling av nye 1-difenylmethylpiperidinderivater.
NO902967L (no) Fremgangsmaate til fremstilling av nye sulfamoyl-tiofener.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000